What is the total market value of antipsychotic drugs market report ?

In 2022, the global antipsychotic drugs market was valued at US$ 17 billion .

Which are the top companies hold the market share in antipsychotic drugs market?

Top companies such as Abbvie inc., Johnson & Johnson, Dr. Reddy's laboratories limited, Bristol-Myers Squibb, and Astrazeneca Plc held a high market position in 2020.

What is the growth rate of the Antipsychotic Drugs Market?

Between 2023 and 2032, this market is estimated to register a CAGR of 5.8%.

Global Antipsychotic Drugs Market, By Therapeutic Class (First Generation, Second Generation, and Third Generation), By Disease (Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, and Other Diseases), By Distribution Channel (Hospital Pharmacies, Drug Stores, and Online Pharmacies), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Published date: Nov 2023
Report ID: 99478
Number of Pages: 346
Format:

- Drive DeVilbissSidhil Ltd.
- ALPS Mountaineering
- Sumitomo Dainippon Pharma Co. Ltd.
- Abbvie Inc
- Alkermes Plc
- AstraZeneca Plc
- Reddy's Laboratories Ltd
- Eli Lilly and Company
- Johnson and Johnson
- Otsuka Holdings Co. Ltd
- Teva Pharmaceutical Industries Ltd
- Bristol-Myers Squibb Company
- Other Key Players